We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

To Compare Fibrin Glue and Suture in Primary Pterygium Excision With Amniotic Membrane Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00457223
Recruitment Status : Completed
First Posted : April 6, 2007
Last Update Posted : February 13, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to compared between conventional pterygium excision and AMT transplantation with suture and with fibrin glue.

Condition or disease Intervention/treatment Phase
Pterygium Procedure: Amniotic membrane transplantation using fibrin glue Phase 2 Phase 3

Detailed Description:

There are few studies about use of fibrin glue in pterygium surgery with conjunctival auto-graft with promising outcome. Less recurrent rate, less discomfort and halve surgical time were reported.

Up to our knowledge,there is no report of fibrin glue in pterygium excision with amniotic membrane transplantation(AMT). There is conventional technique to use AMT in King Chulalongkorn Memorial Hospital because some benefits over conjunctival auto-graft e.g.

  • Preserve healthy superior conjunctiva for future glaucoma filtering surgery
  • Can use in big or 2-headed pterygium
  • Not contract as conjunctival graft esp. in case of fibrin glue
  • Potential easier to use with fibrin glue
  • Available from Thai Red Cross Eye Bank Comparison(s): amniotic membrane transplantation using fibrin glue compare to suture after pterygium excision.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 32 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Randomized Controlled Trial to Compare Fibrin Glue and Suture in Primary Pterygium Excision With Amniotic Membrane Transplantation
Study Start Date : April 2007
Primary Completion Date : August 2007
Study Completion Date : August 2007
Arms and Interventions

Arm Intervention/treatment
Experimental: 1Fibrin glue
After pterygium excision, amniotic membrane was shaped and attached to bare scleral area using fibrin glue (Quixil®)
Procedure: Amniotic membrane transplantation using fibrin glue
After pterygium excision, amniotic membrane was shaped and attached to bare scleral area using fibrin glue (Quixil®) in 16 eyes of 16 patients of FG group and continuous suture with nylon 10-0 in 16 eyes of 16 patients of SU group.
Other Names:
  • Quixil®
  • Nylon 10-0
Active Comparator: 2 Suture
After pterygium excision, amniotic membrane was shaped and attached to bare scleral area using continuous suture with nylon 10-0
Procedure: Amniotic membrane transplantation using fibrin glue
After pterygium excision, amniotic membrane was shaped and attached to bare scleral area using fibrin glue (Quixil®) in 16 eyes of 16 patients of FG group and continuous suture with nylon 10-0 in 16 eyes of 16 patients of SU group.
Other Names:
  • Quixil®
  • Nylon 10-0


Outcome Measures

Primary Outcome Measures :
  1. Pain and discomfort during and after surgery using visual analog scale [ Time Frame: during surgery and after surgery up to 30 days ]

Secondary Outcome Measures :
  1. Surgical time [ Time Frame: start and to the end of surgery ]
  2. Healing of epithelial defect on cornea and AMT [ Time Frame: until 30 days ]
  3. Postoperative inflammation [ Time Frame: up to 30 days ]
  4. Complications e.g. Recurrent, graft loss/dehiscent, re-operation [ Time Frame: until last follow up ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • primary pterygium

Exclusion Criteria:

  • Pregnant women
  • Recurrent pterygium
  • Pseudopterygium
  • Uncontrolled systemic disease.
  • Known allergy to any of the study agents or preservatives used in the formulations.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00457223


Locations
Thailand
Department of Ophthalmology, King Chulalongkorn Memorial hospital
Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University
Investigators
Study Chair: Ngamjit Kasetsuwan, MD Ophthalmology Department, Faculty of Medicine, Chulalongkorn University
More Information

Responsible Party: Ratchadapiseksompotch Fund, Chulalongkorn University, Faculty of Medicine
ClinicalTrials.gov Identifier: NCT00457223     History of Changes
Other Study ID Numbers: 401/49
First Posted: April 6, 2007    Key Record Dates
Last Update Posted: February 13, 2008
Last Verified: February 2008

Keywords provided by Chulalongkorn University:
pterygium
pterygia
excision
amniotic membrane transplantation
fibrin glue
suture

Additional relevant MeSH terms:
Pterygium
Conjunctival Diseases
Eye Diseases
Fibrin Tissue Adhesive
Hemostatics
Coagulants